These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 35470356)

  • 1. Liver injury associated with high value of D-dimer plasmatic level in COVID-19 patients.
    Abenavoli L; Aquila I; Sacco MA; Procopio AC; Cinaglia P; Zanza C; Longhitano Y; Arena V; Fagoonee S; Ricci P; Luzza F
    Minerva Gastroenterol (Torino); 2023 Mar; 69(1):141-148. PubMed ID: 35470356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series.
    Abenavoli L; Aquila I; Sacco MA; Scarlata GGM; Procopio AC; Boccuto L; Scarpellini E; Greco M; Foti DP; Ricci P; Luzza F
    Diseases; 2023 Oct; 11(4):. PubMed ID: 37873785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury.
    Akkiz H
    Viruses; 2023 May; 15(6):. PubMed ID: 37376587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.
    Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T
    Liver Int; 2022 Jun; 42(6):1297-1307. PubMed ID: 35412018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms implicated in SARS-CoV-2 liver tropism.
    Quarleri J; Delpino MV
    World J Gastroenterol; 2022 Dec; 28(48):6875-6887. PubMed ID: 36632318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis.
    Zhang Y; He L; Chen H; Lu S; Xiong Y; Liu J; Zheng Y; Wang S; Liu L
    Int J Lab Hematol; 2020 Dec; 42(6):766-772. PubMed ID: 32592539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early experience with arterial thromboembolic complications in patients with COVID-19.
    Indes JE; Koleilat I; Hatch AN; Choinski K; Jones DB; Aldailami H; Billett H; Denesopolis JM; Lipsitz E
    J Vasc Surg; 2021 Feb; 73(2):381-389.e1. PubMed ID: 32861865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-center cohort.
    Ramirez GA; Calvisi SL; DE Lorenzo R; DA Prat V; Borio G; Gallina G; Farolfi F; Cavallo L; Pascali M; Castellani J; Baccellieri D; Guzzo F; Baiardo Redaelli M; Azzolini ML; Alba AC; Zangrillo A; Bozzolo EP; Scotti R; DI Lucca G; Piemonti L; Rovere Querini P; D'Angelo A; Tresoldi M;
    Minerva Med; 2022 Aug; 113(4):695-706. PubMed ID: 34114439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
    Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
    mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver dysfunction and SARS-CoV-2 infection.
    Gracia-Ramos AE; Jaquez-Quintana JO; Contreras-Omaña R; Auron M
    World J Gastroenterol; 2021 Jul; 27(26):3951-3970. PubMed ID: 34326607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.